Dies ist eine Übersichtsseite mit Metadaten zu dieser wissenschaftlichen Arbeit. Der vollständige Artikel ist beim Verlag verfügbar.
Early Revascularization in Acute Myocardial Infarction Complicated by Cardiogenic Shock
3.087
Zitationen
23
Autoren
1999
Jahr
Abstract
BACKGROUND: The leading cause of death in patients hospitalized for acute myocardial infarction is cardiogenic shock. We conducted a randomized trial to evaluate early revascularization in patients with cardiogenic shock. METHODS: Patients with shock due to left ventricular failure complicating myocardial infarction were randomly assigned to emergency revascularization (152 patients) or initial medical stabilization (150 patients). Revascularization was accomplished by either coronary-artery bypass grafting or angioplasty. Intraaortic balloon counterpulsation was performed in 86 percent of the patients in both groups. The primary end point was mortality from all causes at 30 days. Six-month survival was a secondary end point. RESULTS: The mean age of the patients was 66+/-10 years, 32 percent were women and 55 percent were transferred from other hospitals. The median time to the onset of shock was 5.6 hours after infarction, and most infarcts were anterior in location. Ninety-seven percent of the patients assigned to revascularization underwent early coronary angiography, and 87 percent underwent revascularization; only 2.7 percent of the patients assigned to medical therapy crossed over to early revascularization without clinical indication. Overall mortality at 30 days did not differ significantly between the revascularization and medical-therapy groups (46.7 percent and 56.0 percent, respectively; difference, -9.3 percent; 95 percent confidence interval for the difference, -20.5 to 1.9 percent; P=0.11). Six-month mortality was lower in the revascularization group than in the medical-therapy group (50.3 percent vs. 63.1 percent, P=0.027). CONCLUSIONS: In patients with cardiogenic shock, emergency revascularization did not significantly reduce overall mortality at 30 days. However, after six months there was a significant survival benefit. Early revascularization should be strongly considered for patients with acute myocardial infarction complicated by cardiogenic shock.
Ähnliche Arbeiten
2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure
2021 · 12.555 Zit.
The Effect of Cardiac Resynchronization on Morbidity and Mortality in Heart Failure
2005 · 6.247 Zit.
Cardiac-Resynchronization Therapy with or without an Implantable Defibrillator in Advanced Chronic Heart Failure
2004 · 5.804 Zit.
An International Randomized Trial Comparing Four Thrombolytic Strategies for Acute Myocardial Infarction
1993 · 4.048 Zit.
Long-Term Use of a Left Ventricular Assist Device for End-Stage Heart Failure
2001 · 3.964 Zit.
Autoren
- Judith S. Hochman
- Lynn A. Sleeper
- John G. Webb
- Timothy A. Sanborn
- Harvey D. White
- J. David Talley
- Christopher E. Buller
- Alice K. Jacobs
- James Slater
- Jacques Col
- Sonja M. McKinlay
- Michael H. Picard
- Mark Menegus
- Jean Boland
- Vladimír Džavík
- Christopher Thompson
- S. Chiu Wong
- Richard M. Steingart
- Robert Forman
- Philip E. Aylward
- Emilie Godfrey
- Patrice Desvigne‐Nickens
- Thierry H. LeJemtel
Institutionen
- Columbia University(US)
- St. Luke's-Roosevelt Hospital Center(US)
- New England Research Institutes(US)
- St. Paul's Hospital(CA)
- Cornell University(US)
- NewYork–Presbyterian Hospital(US)
- Greenlane Clinical Centre(NZ)
- Vancouver General Hospital(CA)
- Boston Medical Center(US)
- Cliniques Universitaires Saint-Luc(BE)
- Albert Einstein College of Medicine(US)